Related Experiment Videos
Tumor necrosis factor alpha regulates CXC chemokine receptor expression and function.
R S Jawa1, G A Quaid, M A Williams
1Department of Surgery, University of Cincinnati, College of Medicine, Ohio 45267, USA.
Shock (Augusta, Ga.)
|August 24, 1999
Summary
Tumor necrosis factor alpha (TNFα) differentially regulates neutrophil receptors CXCR-1 and CXCR-2, impacting inflammatory responses. Pretreatment with TNFα significantly alters receptor expression and function, affecting neutrophil chemotaxis and calcium mobilization.
Area of Science:
- Immunology
- Cell Biology
- Inflammation Research
Background:
- Neutrophils are key players in acute inflammation.
- Alpha chemokines, via CXCR-1 and CXCR-2 receptors, direct neutrophil activity.
- Tumor necrosis factor alpha (TNFα) is a critical inflammatory mediator.
Purpose of the Study:
- To investigate the regulatory effects of TNFα pretreatment on CXCR-1 and CXCR-2 expression and function in human neutrophils.
- To understand the differential regulation of these two key inflammatory receptors.
Main Methods:
- Flow cytometry to assess cell surface receptor levels.
- Radioligand binding assays.
- Northern blot analysis for mRNA expression.
- Calcium mobilization assays.
- Chemotaxis experiments to evaluate neutrophil migration.
Main Results:
- TNFα pretreatment significantly decreased surface CXCR-2 levels, with partial recovery.
- CXCR-1 levels sharply declined and remained low after TNFα exposure.
- mRNA levels of both receptors decreased after 2 hours of TNFα pretreatment.
- TNFα pretreatment substantially down-regulated neutrophil chemotaxis to IL-8 and GROα, more than receptor level changes indicated.
- Calcium mobilization responses to IL-8 were minimally affected, but responses to NAP-2 were significantly inhibited.
Conclusions:
- TNFα differentially regulates CXCR-1 and CXCR-2 on human neutrophils.
- These alterations in receptor expression and function impact neutrophil inflammatory behavior.
- The study highlights distinct regulatory mechanisms for IL-8 receptors in response to TNFα.